Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.520
+0.220 (6.67%)
At close: Oct 20, 2025, 4:00 PM EDT
3.546
+0.026 (0.74%)
After-hours: Oct 20, 2025, 6:25 PM EDT
MRVI Revenue
Maravai LifeSciences Holdings had revenue of $47.40M in the quarter ending June 30, 2025, a decrease of -31.73%. This brings the company's revenue in the last twelve months to $219.83M, down -19.95% year-over-year. In the year 2024, Maravai LifeSciences Holdings had annual revenue of $259.19M, down -10.30%.
Revenue (ttm)
$219.83M
Revenue Growth
-19.95%
P/S Ratio
2.14
Revenue / Employee
$385,667
Employees
570
Market Cap
898.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 259.19M | -29.76M | -10.30% |
| Dec 31, 2023 | 288.95M | -594.06M | -67.28% |
| Dec 31, 2022 | 883.00M | 83.76M | 10.48% |
| Dec 31, 2021 | 799.24M | 515.14M | 181.33% |
| Dec 31, 2020 | 284.10M | 140.96M | 98.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
MRVI News
- 2 months ago - Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Maravai LifeSciences Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025 - GlobeNewsWire
- 3 months ago - Johnson Fistel, PLLP Investigates Quantum Computing, AppLovin, Skyworks Solutions, and Maravai LifeSciences - GlobeNewsWire
- 4 months ago - Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer - GlobeNewsWire
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation - Accesswire
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out - Accesswire